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As an alternative to MTA, a new endodontic material based on hydroxyapatite and calcium silicates (ALBO-MPSA) has been
synthesized, and its biocompatibility has been studied in many in vitro and in vivo studies. -e current study aims to evaluate
a subchronic systemic toxicity of ALBO-MPSA on the rat animal model, as a continuation of the previous studies. Biochemical
parameters of blood and histological parameters of the liver, kidneys, and spleen of the rats were analyzed after 120 days of
consumption of the aqueous extract of ALBO-MPSA.-e results showed nomyelotoxic effect or autoimmune effect on peripheral
blood cells and no pathological effect on the liver, kidney, and spleen tissues. Besides, no changes in the skin and hair of the rats,
neither the change in the consumption of food and water, nor the change in their usual behavior were noticed during
the experiment.
1. Introduction
Calcium silicate cements are bioactive materials used in
various endodontic indications, such as pulp capping,
pulpotomy, apexogenesis, apexification, perforation repair,
and root-end filling [1–4]. -e mineral trioxide aggregate
(MTA) is certainly one of the most important and most
widely investigated calcium silicate-based materials due to
its clinical reliability and effective bone inductive potential in
periapical defects after endodontic surgical treatment [5–8].
Biocompatibility of MTA is attributed primarily to its
physicochemical reaction with surrounding tissues and the
release of Ca2+ ions [9].
However, MTA shows many drawbacks during the
clinical application, such as long setting time, difficulty in
handling, and potential discoloration of teeth [10–12], and
therefore, researchers have been trying to introduce new
materials which would overcome these limitations of MTA
(Bioaggregate and Biodentine) [13].
In an attempt to develop appropriate endodontic ce-
ment, a new material based on hydroxyapatite and calcium
silicates (ALBO-MPSA) has been synthesized a few years ago
using the nanotechnology approach [14]. -e bio-
compatibility of ALBO-MPSA has been thoroughly studied
and confirmed at in vitro and in vivo conditions and
compared to MTA [14–21].
-e aim of this paper was to further examine ALBO-
MPSA biocompatibility, over the subchronic toxicity study.
-e effects of systemic toxicity of ALBO-MPSA were
evaluated on the basis of biochemical parameters of blood
and histological parameters of the liver, kidneys, and spleen
of experimental rats after a 120-day period. -e zero
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hypothesis was that ALBO-MPSA does not show significant
systemic toxic effects.
2. Materials and Methods
2.1.Preparationof theTestMaterial. -e test material ALBO-
MPSA is composed of 40% hydroxyapatite, 20% calcium
silicates, 20% gypsum, and 20% BaSO4 as a radiocontrast
agent. Hydroxyapatite and calcium silicates were synthe-
sized using the nanotechnology approach, as it was de-
scribed in detail in our previous references [14–16], while
gypsum dihydrate and BaSO4 were purchased from Whip
Mix Corporation, USA, and Merck, Germany, respectively.
Detailed physicochemical characterization of HA-CS was
given previously [14].
In this study, the aqueous extract of the ALBO-MPSA
was used, which was obtained after immersion of ALBO-
MPSA in distilled water in concentration of 100mg/ml and
decantation after 5 days (in accordance with the standard
ISO 10993-12:2012—Biological evaluation of medical
devices—Part 12: Sample preparation and reference
materials).
2.2. Subchronic Systemic Toxicity Investigation. -e experi-
mental protocol for this investigation was approved by the
Ethical Committee of the Faculty of Veterinary Medicine,
Belgrade, and Ministry of Agriculture and Environment
Protection of the Republic of Serbia (decision number 01-
831/2) and realized in accordance with recommendations of
European Good Laboratory Practice (86/609 EEC) related to
the use and protection of laboratory animals.
2.2.1. Experimental Protocol. -is study was performed in
accordance with the standard ISO 10993-11:2017 (Biological
evaluation of medical devices—Part 11: Tests for systemic
toxicity).
Twenty-five Wistar rats (Rattus norvegicus) at the age of
8–12 weeks and average body weight of 250 ± 10 g were
included in the investigation. -e rats were placed in
properly marked cages and kept in a room for experimental
animals where the room temperature was 23 + 3°C and air
humidity was 55 + 5%, with 8–12 air changes/h, with ar-
tificial lighting at intervals of 12 h day/night. -e animals
had free access to food and water, and their health status was
monitored daily during the experiment.
After the adaptation period of 7 days, these 25 animals
were randomly divided into two groups: experimental (15
animals) and control (10 animals) groups.-e animals in the
experimental group were given 1ml of the aqueous extract of
the ALBO-MPSA everyday at the same time during 120 days,
and the animals in the control group were given 1ml of
distilled water.
Health status of the rats, their behavior, changes in the
skin and hair, changes in food and water consumption, and
changes in urination and defecation were monitored and
recorded daily during the experiment. -e body weight of
experimental animals was checked at the beginning of the
experiment and then every forty days to the end of the
experiment.
2.2.2. Blood Analysis. On the last day of the experiment,
blood samples were taken from the lateral tail vein of all
animals for complete blood analysis (leukocytes, hemoglobin,
and platelets), including analysis of biochemical parameters of
the blood: the levels of alanine aminotransaminase (ALT) and
aspartate aminotransaminase (AST), to evaluate the function
of the liver, and levels of urea, creatinine, and bilirubin, to
evaluate the function of kidneys. Also, the values of serum
protein, glucose, and alkaline phosphatase (ALP) were
determined.
2.3.3. Histopathological Analysis. After 120 days, the rats
from both control and experimental groups were sacrificed
by intravenous administration of thiopentone sodium so-
lution at a dose of 170mg/kg, and the tissue samples of the
liver, kidneys, and spleen from each animal were taken for
the histopathological analysis. -e tissue samples were fixed
in 10% buffered formalin solution and then processed by the
routine procedure. One paraffin block from the liver, kid-
neys, and spleen was made for each animal, after which 5 μm
thick tissue sections were made from paraffin blocks and
dyed by hematoxylin-eosin (HE).
Semiquantitative histopathological analysis of liver tis-
sue samples included an evaluation of the following pa-
rameters: the presence of inflammatory infiltrates in the
portal tract and its graduation 0–3: 0—without infiltrates,
1—mild infiltration, 2—moderate infiltration, and 3—strong
infiltration, the dominant cells’ type in inflammatory in-
filtrates (lymphocytes or neutrophils), and other changes
(degenerative and similar) in portal spaces. In the lobules of
the liver, the following parameters were investigated: the
intensity of inflammatory changes, the type of hepatocyte
necrosis, the occurrence of steatosis, binuclear hepatocytes,
and the accumulation of pigments in hepatocytes. -e
lobular necroinflammatory intensity is semiquantitatively
graduated (0—without lobular activity, 1—light lobular
activity with 1–3 necrosis per lobule, 2—moderate with 3–5
necrosis per lobule, and 3—strong with more than 5 necrosis
per lobule). As part of the lobular activity, enlargement and
hyperplasia of Kupffer’s cells in sinusoids were studied
(0—no change, 1—light hyperplasia of Kc, 2—moderate
hyperplasia of Kc, and 3—severe hyperplasia of Kc).
Analysis of kidney tissue samples included an evaluation
of the presence of interstitial haemorrhage and its gradua-
tion (0—without haemorrhage, 1—focal and rare haemor-
rhage in less than 10% of the sample, 2—moderate
haemorrhage in 10–30% of the sample, and 3—severe, ex-
tensive haemorrhage in more than 40% of the sample) and
degenerative changes of the tubular epithelium and tubular
dilatation (0—without degenerative changes and dilatation,
1—light degenerative changes and dilatation of up to 10% of
tubules in the sample, 2—moderate degenerative changes
and dilatation of 10–30% of tubules in the sample, and
3—strong degenerative changes and dilatation of more than
30% of tubules in the sample), as well as semiquantitative
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analysis of the presence of inammatory inltrates in the
kidney interstitium (0—without inammatory inltrate,
1—mild inammation, 2—moderate inammation, and
3—severe inammation) and determination of the domi-
nant type of cells in the inammatory inltrate (lymphocytes
and neutrophils). Also, the presence of the foci of glomerular
collapse has also been evaluated.
In the tissue samples of the spleen, the presence of
congestion in red pulp and the existence of white pulp
hypertrophy (0—no hypertrophy, 1—light hypertrophy,
2—moderate hypertrophy, and 3—severe hypertrophy) were
estimated.
Statistical analysis was performed using the SPSS soft-
ware (version 2010; Chicago, IL, USA).
3. Results
3.1. Clinical Symptoms and Observations. By daily moni-
toring of the tested animals, no adverse eects related to
their behavior, no changes in skin and hair, no changes in
food and water consumption, and no changes in urination
and defecation have been observed. Body weight of all
animals mildly and consistently increased during the ob-
servation period (Figure 1).
3.2. Results of Blood Analysis. Blood analysis showed that
there was no statistically signicant dierence between the
hemoglobin and thrombocyte values in the experimental
and control groups, but the leukocyte values were signi-
cantly higher in the control group than in the experimental
group (p< 0.001; Table 1).
Analysis of the biochemical parameters (Table 2) showed
that the ALT level was similar in the experimental and
control groups, while the AST level was higher in the control
group than in the experimental group, but without signif-
icant dierences. Urea, creatinine, bilirubin, glucose, and
ALP values were similar in experimental and control groups
and without statistically signicant dierences.
3.3. Results of Semiquantitative Histopathological Analysis.
Histopathological analysis of the liver tissue pointed out the
absence or eventually the presence of a mild inammatory
inltrate in the portal liver areas. A mild inammatory
reaction with eosinophils inltration was more common in
the experimental group of rats but not statistically signi-
cantly higher in comparison to the control group (Figure 2).
No degenerative changes in the biliary ductal epithelium
of the liver were observed in the experimental group nor in
the control group. Necrosis of individual hepatocytes in
lobules, marked by a slight lymphocyte inammatory in-
ltrate, was registered in more than 50% of samples in the
experimental and control groups. Moderate lobular activity
was registered only in two cases in the experimental group
(13.3%) (Figure 3).
Fatty changes in hepatocytes were not observed in any
case, while binuclear hepatocytes were observed only in 20%
of cases in the experimental group (Figure 4).
An analysis of reactive changes in the liver indicated
mainly a slight increase in Kuper’s cells, while a moderate
increase was recorded in 26.7% of cases in the experimental
group.
Histopathological analysis of the kidney tissue showed
no interstitial bleeding in any case and a slight collapse of
rare glomeromas in 6.7% of cases in the experimental group.
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Figure 1: Average body weights of experimental and control
animals during the study of subchronic systemic toxicity of the
dental material ALBO-MPSA.
Table 1: Results of blood analysis.
ALBO-MPSA Control
Leukocytes 3.00 ± 1.63 6.83 ± 0.77
Hemoglobin 132.38 ± 46.1 140.8 ± 6.76
rombocytes 431.67 ± 257.28 713.20 ± 181.58
Table 2: Results of analysis of biochemical parameters.
ALBO-MPSA Control
ALT 57.54 ± 17.83 71.50 ± 31.11
AST 412.62 ± 303.70 844.32 ± 838.57
Urea 5.13 ± 1.05 5.21 ± 0.36
Creatinine 38.23 ± 4.44 40.00 ± 4.84
Bilirubin 1.35 ± 0.41 1.01 ± 0.32
Glucose 5.59 ± 1.36 5.48 ± 0.99
ALP 69.62 ± 8.87 63.00 ± 9.80
Figure 2: A normal-sized portal tract with a slight inammatory
inltrate with eosinophils included (HE, x400).
Advances in Materials Science and Engineering 3
Degenerative changes in the tubular kidney epithelium were
not observed in any rat. Inflammatory infiltrate in the
interstitium was observed in 6.7% of cases in the experi-
mental group consisting of lymphocytes (100%) and in
55.6% of cases in the control group where lymphocytes were
present in 60% of cases (Figure 5).
Histopathological analysis of the spleen tissue showed
mildly atrophic or hypertrophic changes in the white pulp
(present in 20% of cases in the experimental group and
11.1% of cases in the control group), while in red pulp,
mostly mild congestion was registered (in 100% of cases in
the experimental group and 77.8% of cases in the control
group).
4. Discussion
During the 120-day period, experimental rats were daily
given the aqueous extract of ALBO-MPSA, and during that
period, no changes in their skin, hair, and usual behavior
were noticed.
An analysis of hematological parameters of blood after
120 days revealed no significant differences between the
experimental and control groups. -ere was no myelotoxic
effect or autoimmune effect on peripheral blood cells which
may be due to the fact that that the tested material was not in
contact with blood [13, 22] but also due to the chemical
composition of the material whose biocompatibility has
already been confirmed in many studies [14–21].
-emorphometric analysis of the liver tissue pointed out
the absence of a mild inflammatory reaction in the portal
areas of liver in the control and experimental groups, which
indicates that there was no significant damage to the liver
[1, 13, 23, 24]. Also, the absence of degenerative changes in
the biliary ductal epithelium and the rare, mild, and mod-
erate necrosis confirmed that ALBO-MPSA had very low
and insignificant impact on the liver tissue [25–27]. Fatty
changes in hepatocytes have not been observed. A slight and
moderate increase in Kupffer’s cells was noticed indicating
an increased mitotic activity of hepatocytes in both the
control and experimental rats [28–31]. Increased activity of
the liver was also indicated by an increase in the number and
density of the cells and a moderate increase in the liver
sinusoids and hepatocyte surface [25, 32]. In addition, the
levels of AST, ALT, and ALP in the blood, which indicate
liver damage, were not significantly different in the control
and experimental groups, also indicating that there was no
hepatocellular liver injury [24, 26].
Histological analysis of the kidney tissue indicated no
bleeding in any case, while a mild glomerular collapse was
registered in a small number of cases. -e values of bio-
chemical parameters referring to kidneys (urea, creatinine,
and bilirubin) were also almost identical in the experimental
and control groups, pointing out that there was no kidney
damage. No degenerative changes in the tubular kidney
epithelium and a minority of cases with inflammatory in-
filtration in the interstitium also indicated a low potential
toxic effect of ALBO-MPSA [13, 33].
An analysis of the spleen tissue revealed the presence of
light hypertrophic changes in white pulp and a mild con-
gestion in red pulp, but these changes did not affect the
function of the spleen and its immune response, which also
testifies the nontoxicity of ALBO-MPSA [1, 13].
All these results of the systemic toxicity investigation of
ALBO-MPSA showed that there was no negative effect on
the liver, kidneys, and spleen, which confirmed the zero
hypothesis.
However, there are opposite findings about the bio-
compatibility of calcium silicate-based materials (MTA,
Bioaggregate) which indicate that these materials adversely
affect the liver and kidneys of the rat, causing significant
inflammatory reactions in comparison to the control group
Figure 4: Binocular hepatocytes with anisocytosis (HE, x400).
Figure 5: Inflammatory infiltrate inside the kidney interstitium
(HE, x400).
Figure 3: Centrolobular area of the liver tissue with 2 focal he-
patocyte necrosis (HE, x400).
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[13, 34, 35]. Harmful effects are explained by the presence of
small amounts of arsenic in the MTA material [12] which
exceed the level recommended by the International Orga-
nization for Standardization [36–39].-is makes the present
study, together with the previous biocompatibility studies of
the new endodontic material ALBO-MPSA [14–21], very
important as they give evidence about safety of the new
material which would be used in the future in dental practice
as an alternative to more toxic currently available materials.
5. Conclusions
-e present study of subchronic systemic toxicity revealed
that the new endodontic material ALBO-MPSA did not
cause any pathological effect on the liver, kidney, and spleen
tissues of the animal rat model, after oral application during
4months. Also, it did not lead to changes in the skin and hair
and did not affect the consumption of food and water,
urination and defecation, and usual behavior of the ex-
perimental animals. -e results of this study together with
the results of previous biocompatibility studies prove that
ALBO-MPSA is safe for application in dental medicine.
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